FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer

W Siggelkow, W Rath, U Buell, M Zimny - European Journal of Nuclear …, 2004 - Springer
… cancer and clarification of disease extent when tumour marker levels are elevated in an …
of FDG PET and tumour marker assay (ie use of FDG PET when warranted by tumour marker

Usefulness of combined FDG-PET with CT or tumour markers in lung cancer diagnosis

K Kley, P Oehr - Anticancer research, 2010 - ar.iiarjournals.org
… were obtained compared to FDG-PET (13). The aim of this investigation was to explore
whether there is synergy between FDG-PET, CT and serum tumour markers in lung cancer …

Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer

L Evangelista, Z Baretta, L Vinante, AR Cervino… - European journal of …, 2011 - Springer
… [8], PET/CT can be of value in … of tumour markers, CT and 18 F-FDG PET/CT in identification
of disease relapse in patients with BC already treated and (2) to assess the impact of PET/…

… FDG-PET/CT in the post-treatment evaluation of endometrial carcinoma: a comparison of PET/CT findings with conventional imaging and CA 125 as a tumour marker

PO Kara, T Kara, B Kaya, GK Gedik, O Sari - Revista Española de Medicina …, 2012 - Elsevier
… of PET/CT with CA 125 as a serum tumour marker for different cut-off values. This retrospective
study was designed to assess the value of FDG-PET… and to compare PET/CT scan with CI …

Fdg pet and pet/ct

BJ Krause, S Schwarzenböck… - Molecular imaging in …, 2012 - Springer
… 62 year old patient under suspicion of bronchial cancer of the left upper lobe referred for
FDG PET/CT for primary staging. FDG PET/CT revealed FDG-positive primary tumour and …

Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous …

K Strobel, B Bode, R Dummer, P Veit-Haibach… - European journal of …, 2009 - Springer
tumour marker, indicating the presence of distant metastases and reflecting the tumour
The aim of this study was to evaluate the value of 18 F-FDG PET/CT and the tumour marker

The role of FDG-PET/CT in the detection of recurrent colorectal cancer

J Votrubova, O Belohlavek, M Jaruskova… - European journal of …, 2006 - Springer
… All of them were FDG-PET/CT positive. Of the 39 patients without recurrent disease, 37
had normal levels of tumour markers, one had increased CEA levels at the time of the FDG-PET/…

Early diagnosis of recurrent breast cancer with EDG-PET in patients with progressive elevation of serum tumor markers

M Suarez, MJ Perez-Castejon… - … Quarterly Journal of …, 2002 - search.proquest.com
… performances of tumour marker guided FDG-PET per patient are … the clinical utility of tumour
marker-guided PET in the follow-up of … None of these focal uptakes shown by FDGPET were …

… cancer before primary treatment: correlation between tumour burden assessed by [18F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125

A Glickman, P Paredes, N Carreras-Diéguez… - European …, 2022 - Springer
… We included 66 patients who underwent 2-[ 18 F]FDG PET/CT and serum tumour
markers determination before primary treatment. Volumes of interest were delimited in every …

Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours

U Lassen, G Daugaard, A Eigtved, L Højgaard… - European journal of …, 2003 - Springer
tumour markers is negative. In this study, 46 patients underwent FDG-PET after staging with
normal CT and tumour markers. … tumour marker evaluation, even though the initial FDG-PET